MDGL

MADRIGAL PHARMACEUTICALS INC

Healthcare | Mid Cap

-$3.26

EPS Forecast

$167.9

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-09-30
PRTAProthena Corp Public Ltd CoHRMYHarmony Biosciences Holdings IncINSMInsmed IncMNKDMannkind CorpRCUSArcus Biosciences IncXNCRXencor IncCYTKCytokinetics IncENTAEnanta Pharmaceuticals IncTBPHTheravance Biopharma Inc